参考文献
|
-
黃碧松,賴振源(2014)。乳癌臨床診治思維。傳統醫學雜誌,25(1),63-91。
連結:
-
黃碧松,賴振源(2014)。乳癌臨床診治思維。傳統醫學雜誌,25(1),63-91。
連結:
-
廖麗蘭,許中華(2017)。乳癌中西醫療法的探討。中醫內科醫學雜誌,15(1),11-27。
連結:
-
認識乳癌化學治療之Taxotere。高雄市立小港醫院(委託財團法人高雄醫學大學經營)。2008.12取自:https://www.kmsh.org.tw/hygr_Edu/hygr/20180306137.pdf
-
109 年死因結果分析(含附表)。衛生福利部。2021; 1-7.。https://www.mohw.gov.tw/dl-71446-e142a47c-14b3-4cef-8d80-f8e5747e8eb2.html
-
108 年癌症登記報告。衛生福利部國民健康署。2021;70-71.https://www.hpa.gov.tw/Pages/ashx/File.ashx?FilePath=~/File/Attach/14913/File_18302.pdf
-
Alexander, S(2009).Malignant fungating wounds: epidemiology, aetiology, presentation and assessment.J Wound Care,18(7),273-280.
-
Alexander, S.(2009).Malignant fungating wounds: key symptoms and psychosocial.J Wound Care,18(8),325-329.
-
Balduzzi, S.,Mantarro, S.,Guarneri, V.,Tagliabue, L.,Pistotti, V.,Moja, L.,D'Amico, R.(2014).Trastuzumab-containing regimens for metastatic breast cancer.Cochrane Database Syst Rev,2014(6),CD006242.
-
Baselga, J.,Cortés, J,Kim, S.B.,Im, S.A,Hegg, R.,Im, Y.H.,Roman, L.,Pedrini, J.L.,Pienkowski, T,Knott, A.,Clark, E.,Benyunes, M.C,Ross, G.,Swain, S.M.,CLEOPATRA Study Group(2012).Pertuzumab plus trastuzumab plus docetaxel for metastatic breast cancer.N Engl J Med.,366(2),109-119.
-
Chlebowski RT. Factors that modify breast cancer risk in women. UpToDate. 2021. 1-31.
-
Colon-Echevarria, CB,Lamboy-Caraballo, R,Aquino-Acevedo, AN,Armaiz-Pena, GN(2019).Neuroendocrine Regulation of Tumor-Associated Immune Cells.Front Oncol,9,1077.
-
Grocott, P(1995).The palliative management of fungating malignant wounds.J Wound Care,4(5),240-242.
-
Hirst, DG(1992).Annual report of the Cancer Research Campaign Grey LaboratoryAnnual report of the Cancer Research Campaign Grey Laboratory,未出版
-
Joe BN. Clinical features, diagnosis, and staging of newly diagnosed breast cancer. UpToDate. 2021. 1-34.
-
Morison, M.(ed.),Moffatt, C.(ed.),Bridel Nixon, J.(ed.),Bale, S(ed.)(1997).Nursing Management of Chronic Wounds.London:Mosby.
-
Sung, H,Ferlay, J,Siegel, RL,Laversanne, M,Soerjomataram, I,Jemal, A,Bray, F(2021).Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.CA Cancer J Clin,71(3),209-249.
-
Swain, S.M,Baselga, J.,Kim, S.B.,Ro, J.,Semiglazov, V.,Campone, M.,Ciruelos, E.,Ferrero, J.M.,Schneeweiss, A.,Heeson, S.,Clark, E.,Ross, G.,Benyunes, M.C,Cortés, J.,CLEOPATRA Study Group(2015).CLEOPATRA Study Group. Pertuzumab, trastuzumab, and docetaxel in HER2-positive metastatic breast cancer.N Engl J Med.,372(8),724-734.
-
王執中。王執中(1220):針灸資生經。中醫笈成資料庫。2021更新。取自:https://jicheng.tw/tcm/book/%E9%87%9D%E7%81%B8%E8%B3%87%E7%94%9F%E7%B6%93/index.html。https://jicheng.tw/tcm/book/%E9%87%9D%E7%81%B8%E8%B3%87%E7%94%9F%E7%B6%93/index.html
-
朱震亨。朱震亨(1347):格致餘論。中醫笈成資料庫。2021更新。取自:https://jicheng.tw/tcm/book/%E6%A0%BC%E8%87%B4%E9%A4%98%E8%AB%96/index.html。https://jicheng.tw/tcm/book/%E6%A0%BC%E8%87%B4%E9%A4%98%E8%AB%96/index.html
-
朱震亨,高叔宗(輯校)。朱震亨原著、高叔宗輯校(1543):丹溪治法心要。中醫笈成資料庫。2021更新。取自:https://jicheng.tw/tcm/book/%E4%B8%B9%E6%BA%AA%E6%B2%BB%E6%B3%95%E5%BF%83%E8%A6%81/index.html。https://jicheng.tw/tcm/book/%E4%B8%B9%E6%BA%AA%E6%B2%BB%E6%B3%95%E5%BF%83%E8%A6%81/index.html
-
余景和(編輯),尚冰(校註)(2015).外證醫案匯編.北京:中國中醫藥出版社.
-
吳金娜,韓向暉,葉依依,黃曼,劉勝(2013)。桔梗配伍不同治則中藥對乳腺癌肺轉移的影響。癌症進展,11(2),159-167。
-
吳謙(2011).醫宗金鑒.山西:山西科學技術出版社.
-
李軍,王鏡輝,王倩,王慶學,羅莉,唐東昕(2018)。乳腺癌中醫診治思路淺析。中國民族民間醫藥,27(15),5-6+32。
-
巢元方。巢元方(614):諸病源候論。中醫笈成資料庫。2021更新。取自:https://jicheng.tw/tcm/book/%E8%AB%B8%E7%97%85%E6%BA%90%E5%80%99%E8%AB%96/index.html。https://jicheng.tw/tcm/book/%E8%AB%B8%E7%97%85%E6%BA%90%E5%80%99%E8%AB%96/index.html
-
郭栴子,朱中博,楊碩,楊燕瑩,黃芊,李康樂,竇建衛(2020)。乳腺癌之情志論。遼寧中醫雜誌,47(12),71-73。
-
陳實功。陳實功(1617):外科正宗。中醫笈成資料庫。2021更新。取自:https://jicheng.tw/tcm/book/%E5%A4%96%E7%A7%91%E6%AD%A3%E5%AE%97/index.html。https://jicheng.tw/tcm/book/%E5%A4%96%E7%A7%91%E6%AD%A3%E5%AE%97/index.html
-
楊繼州(1994).針灸大成.台北:大中國圖書公司.
-
薛己。薛己(1237):校註婦人良方。中醫笈成資料庫。2021更新。取自:https://jicheng.tw/tcm/book/%E6%A0%A1%E8%A8%BB%E5%A9%A6%E4%BA%BA%E8%89%AF%E6%96%B9/index.html。https://jicheng.tw/tcm/book/%E6%A0%A1%E8%A8%BB%E5%A9%A6%E4%BA%BA%E8%89%AF%E6%96%B9/index.html
|